Evaluation of the awareness of novel advanced therapies among family medicine residents in Spain
MetadataShow full item record
AuthorSola, Miguel; Sánchez Quevedo, María Del Carmen; Martín Piedra, Miguel Ángel; Carriel Araya, Víctor; Garzón Bello, Ingrid Johanna; Chato-Astrain, Jesús; García García, Óscar Darío; Alaminos Mingorance, Miguel; Campos, Fernando
Sola M, Sanchez-Quevedo C, Martin- Piedra MA, Carriel V, Garzon I, Chato-Astrain J, et al. (2019) Evaluation of the awareness of novel advanced therapies among family medicine residents in Spain. PLoS ONE 14(4): e0214950.
SponsorshipThis work was supported by CTS-115 (Tissue Engineering Group), Junta de Andalucia.
Advanced therapies are increasingly demanded by patients with the intent of treating some incurable conditions. Because family medicine professionals play an important role as health educators, their residency programs should incorporate new knowledge related to advanced therapies. To successfully implement these programs, how family medicine residents perceive these therapies should be investigated. The main components of perception, i.e. conceptual, procedural and attitudinal, refer to knowledge, skills and feelings, respectively. We designed a specific questionnaire to assess the components of perceptions of advanced therapies in 300 medical residents enrolled in the Spanish National Family Medicine Residency Program. Each component consisted of 4 or 5 topics and each topic contained 6 items. Respondents scored highest in the procedural component (average 4.12±1.00), followed by the attitudinal (3.94±1.07) and conceptual component (3.04±1.43). Differences among the three components were statistically significant (p<0.00017). Family medicine residents perceived that procedures to implement advanced therapies are well established, especially their application. However, they felt their cognitive background was insufficient to respond efficiently to the expectations generated by these new therapeutic tools, especially in the regulatory framework. High awareness of the risks and limitations of these treatments was reflected by residents’ preference for clinically tested therapies. Although they appropriately situated treatment with these therapies within hospital care, they associated the biofabrication of novel products with research centers, although these therapeutic tools can be produced in different facilities. These results are potentially useful for designing future training programs and health policies for family medicine residents, and suggest the need to implement specific training programs in advanced therapies at the conceptual, procedural and attitudinal level.